Thomas H Corbett Selected Research

symplostatin 3

1/2002

Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas H Corbett Research Topics

Disease

10	Neoplasms (Cancer) 06/2005 - 01/2002
2	Leukemia 07/2003 - 02/2002
2	Adenocarcinoma 07/2003 - 07/2003
1	Necrosis 06/2004

Drug/Important Bio-Agent (IBA)

3	XK 469 (XK469)IBA 06/2005 - 02/2002
3	cryptophycin 52 (cryptophycin-52)IBA 09/2004 - 07/2003
2	Pharmaceutical PreparationsIBA 09/2004 - 06/2004
1	propionic acid (potassium propionate)IBA 06/2005
1	cryptophycinIBA 06/2005
1	QuinoxalinesIBA 02/2005
1	quinolineIBA 02/2005
1	Biological ProductsIBA 09/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2004
1	cryptophycin 1IBA 09/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2004
1	N-acetylcochinol-O-phosphateIBA 06/2004
1	cremophorIBA 07/2003
1	cryptophycin 55IBA 07/2003
1	Epoxy Compounds (Epoxides)IBA 07/2003
1	ProdrugsIBA 07/2003
1	symplostatin 1IBA 04/2003
1	AgarIBA 02/2003
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2003
1	Gemcitabine FDA Link 02/2002
1	Dacarbazine (DIC)FDA LinkGeneric 02/2002
1	Carmustine (FIVB)FDA Link 02/2002
1	Etoposide (VP 16)FDA LinkGeneric 02/2002
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2002
1	symplostatin 3IBA 01/2002
1	dolastatin 10IBA 01/2002